Alkem Labs Receives Rs 9.72 Lakh GST Demand for FY 2021-22

The GST order mainly alleges the levy of tax under the Reverse Charge Mechanism and excess availment of Input Tax Credit (ITC).

Written By :  Parthika Patel
Published On 2026-01-03 11:02 GMT   |   Update On 2026-01-03 11:02 GMT
Advertisement

Calcutta: Alkem Laboratories Limited has received an order under the Goods and Services Tax (GST) Act, 2017, from the Deputy Commissioner, Large Taxpayer Unit, Corporate Division, West Bengal, raising a tax demand of Rs 9,71,866 for the financial year 2021-22.

The order, pertaining to the company’s West Bengal GSTIN, was received on December 29, 2025.

In a regulatory filing, the company stated that the statutory authority has demanded GST of Rs 5,20,601, along with interest amounting to Rs 3,89,167 and a penalty of Rs 62,098. The demand has been raised under the applicable provisions of the IGST Act, 2017, CGST Act, 2017, and SGST Act, 2017.

Advertisement

According to the details disclosed, the GST order mainly alleges the levy of tax under the Reverse Charge Mechanism and excess availment of Input Tax Credit (ITC). Alkem Laboratories has clarified that it does not agree with the allegations and the demand raised in the order.

The company further stated that it is in the process of taking appropriate legal action, including but not limited to filing an appeal against the order before the competent authority. Alkem Laboratories emphasized that the GST demand will not have any material impact on its financial position, operations, or other business activities.

Alkem Laboratories also informed that the details of the order have been uploaded on its official website for stakeholder information.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News